Purdue Pharma LP

General

Total Cases176

Active Cases8

Patents669

CourtsD. Delaware S.D. New York D. New Jersey

TypeNPE

Elite Ratings

--

purduepharma.com

Ratings

Experience

Grade

Trend

DCT

L3

A

PTAB

L4

E

CAFC

L3

E

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
09/09/24	Purdue Pharma L.P. v. Accord Healthcare Inc. 1:22-CV-00913 ( D. DE )	FINAL Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,304,908 B2; 11,304,909 B2. (mpb) (Entered: 09/09/2024)
09/09/24	Purdue Pharma L.P. v. Accord Healthcare Inc. 1:22-CV-00913 ( D. DE )	FINAL Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,304,908 B2; 11,304,909 B2. (mpb) (Entered: 09/09/2024)
09/09/24	Purdue Pharma L.P. v. Accord Healthcare Inc. 1:22-CV-00913 ( D. DE )	FINAL JUDGMENT: Claims 1, 10, 18, 23, 28, and 29 of the '908 patent are declared to be invalid on the ground of obviousness, under 35 U.S.C. § 103. In view of the Court's rulings that the asserted claims of the 908 patent are invalid, judgment is granted in favor of Defendant on each of Plaintiffs' claims of patent infringement with respect to that patent. Pursuant to entry of this Final Judgment, all other claims and counterclaims shall be dismissed without prejudice as moot, subject to reinstatement upon reversal or remand. (CASE CLOSED) Signed by Judge William C. Bryson on 9/9/2024. (mpb) (Entered: 09/09/2024) FINAL JUDGMENT: Claims 1, 10, 18, 23, 28, and 29 of the '908 patent are declared to be invalid on the ground of obviousness, under 35 U.S.C. § 103. In view of the Court's rulings that the asserted claims of the 908 patent are invalid, judgment is granted in favor of Defendant on each of Plaintiffs' claims of patent infringement with respect to that patent. Pursuant to entry of this Final Judgment, all other claims and counterclaims shall be dismissed without prejudice as moot, subject to reinstatement upon reversal or remand. (CASE CLOSED) Signed by Judge William C. Bryson on 9/9/2024. (mpb) (Entered: 09/09/2024)
09/09/24	Purdue Pharma L.P. v. Accord Healthcare Inc. 1:22-CV-00913 ( D. DE )	FINAL JUDGMENT: Claims 1, 10, 18, 23, 28, and 29 of the '908 patent are declared to be invalid on the ground of obviousness, under 35 U.S.C. § 103. In view of the Court's rulings that the asserted claims of the 908 patent are invalid, judgment is granted in favor of Defendant on each of Plaintiffs' claims of patent infringement with respect to that patent. Pursuant to entry of this Final Judgment, all other claims and counterclaims shall be dismissed without prejudice as moot, subject to reinstatement upon reversal or remand. (CASE CLOSED) Signed by Judge William C. Bryson on 9/9/2024. (mpb) (Entered: 09/09/2024) FINAL JUDGMENT: Claims 1, 10, 18, 23, 28, and 29 of the '908 patent are declared to be invalid on the ground of obviousness, under 35 U.S.C. § 103. In view of the Court's rulings that the asserted claims of the 908 patent are invalid, judgment is granted in favor of Defendant on each of Plaintiffs' claims of patent infringement with respect to that patent. Pursuant to entry of this Final Judgment, all other claims and counterclaims shall be dismissed without prejudice as moot, subject to reinstatement upon reversal or remand. (CASE CLOSED) Signed by Judge William C. Bryson on 9/9/2024. (mpb) (Entered: 09/09/2024)
09/09/24	Purdue Pharma L.P. v. Accord Healthcare Inc. 1:22-CV-00913 ( D. DE )	FINDINGS OF FACT AND CONCLUSIONS OF LAW Signed by Judge William C. Bryson on 9/9/2024. (mpb) (Entered: 09/09/2024)
09/09/24	Purdue Pharma L.P. v. Accord Healthcare Inc. 1:22-CV-00913 ( D. DE )	FINDINGS OF FACT AND CONCLUSIONS OF LAW Signed by Judge William C. Bryson on 9/9/2024. (mpb) (Entered: 09/09/2024)
07/22/24	Purdue Pharma L.P. v. Accord Healthcare Inc. 1:22-CV-00913 ( D. DE )	ORAL ORDER. The court will hold oral argument on the post-trial briefing at 10:00 a.m. on August 9, 2024, via Zoom. The log-in information will be provided to counsel via email in advance of the argument. Signed by Judge William C. Bryson on 7/22/2024. (ndw) (Entered: 07/22/2024)
07/22/24	Purdue Pharma L.P. v. Accord Healthcare Inc. 1:22-CV-00913 ( D. DE )	ORAL ORDER. The court will hold oral argument on the post-trial briefing at 10:00 a.m. on August 9, 2024, via Zoom. The log-in information will be provided to counsel via email in advance of the argument. Signed by Judge William C. Bryson on 7/22/2024. (ndw) (Entered: 07/22/2024)
07/16/24	Purdue Pharma LP v. Elite Laboratories Inc 1:23-CV-22221 ( D. NJ )	STIPULATION AND ORDER TO EXTEND STAY OF ALL PROCEEDINGS. Signed by Magistrate Judge Ann Marie Donio on 7/15/2024. (mag) (Entered: 07/16/2024)
07/16/24	Purdue Pharma LP v. Elite Laboratories Inc 1:23-CV-22221 ( D. NJ )	STIPULATION AND ORDER TO EXTEND STAY OF ALL PROCEEDINGS. Signed by Magistrate Judge Ann Marie Donio on 7/15/2024. (mag) (Entered: 07/16/2024)